E- News
Entertainment News Hub
USD USD 1.00 EUR EUR 0.85
USD USD 1.00 GBP GBP 0.73
USD USD 1.00 JPY JPY 143.67
USD USD 1.00 CAD CAD 1.36
USD USD 1.00 AUD AUD 1.52
USD USD 1.00 CHF CHF 0.79
USD USD 1.00 CNY CNY 7.16
USD USD 1.00 INR INR 85.67
USD USD 1.00 NGN NGN 1,530.38
USD USD 1.00 EUR EUR 0.85
USD USD 1.00 GBP GBP 0.73
USD USD 1.00 JPY JPY 143.67
USD USD 1.00 CAD CAD 1.36
USD USD 1.00 AUD AUD 1.52
USD USD 1.00 CHF CHF 0.79
USD USD 1.00 CNY CNY 7.16
USD USD 1.00 INR INR 85.67
USD USD 1.00 NGN NGN 1,530.38



ESSENTIAL NEWS

Breaking News • Analysis • Opinion
LATEST EDITION

LOCAL

Nafdac Uncovers Rifles, Weapons During Fake Drug Raid In Onitsha Marke
Photo: Staff Photographer

NAFDAC UNCOVERS RIFLES, WEAPONS DURING FAKE DRUG RAID IN ONITSHA MARKE

20 readers
shares
reactions
I

In a significant crackdown on counterfeit pharmaceuticals, the National Agency for Food and Drug Administration and Control (NAFDAC) uncovered a cache of weapons concealed within the Ogbo-Ogwu Drug Market at the Onitsha Bridgehead in Anambra State.  The discovery included rifles, live cartridges, machetes, and daggers, believed to have been hidden by individuals involved in the distribution of fake drugs with the intent to attack enforcement officials.  

The operation, which commenced on February 10, 2025, led to the seizure of 50 trailer loads of counterfeit and substandard drugs.  These illicit products have been transported to NAFDAC laboratories for further analysis.  

Dr. Martins Iluyomade, NAFDAC’s South-East Zonal Director, expressed concern over the lengths to which counterfeit drug dealers would go to protect their illegal activities.  He noted that several individuals attempting to retrieve the seized drugs or interfere with the operation have been arrested and are currently providing valuable information to authorities.  

NAFDAC has acknowledged the cooperation of market leaders during the enforcement exercise and has announced plans to reopen certain sections of the market as the agency progresses to the next phase of its operation.

This development underscores the challenges faced by regulatory bodies in combating the distribution of counterfeit drugs and highlights the need for continued vigilance and collaboration to safeguard public health.
 

"This represents a significant development in our ongoing coverage of current events."
— Editorial Board

READER ENGAGEMENT

SHARE THIS STORY

MORE FROM THIS EDITION

Additional articles loading...